| Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and-resistant strains of Leishmania donovani that … R Basu, S Bhaumik, JM Basu, K Naskar, T De, S Roy The journal of immunology 174 (11), 7160-7171, 2005 | 293 | 2005 |
| Sodium antimony gluconate induces generation of reactive oxygen species and nitric oxide via phosphoinositide 3-kinase and mitogen-activated protein kinase activation in … J Mookerjee Basu, A Mookerjee, P Sen, S Bhaumik, P Sen, S Banerjee, ... Antimicrobial agents and chemotherapy 50 (5), 1788-1797, 2006 | 206 | 2006 |
| Inhibition of ABC Transporters Abolishes Antimony Resistance in Leishmania Infection J Mookerjee Basu, A Mookerjee, R Banerjee, M Saha, S Singh, K Naskar, ... Antimicrobial agents and chemotherapy 52 (3), 1080-1093, 2008 | 109 | 2008 |
| Antimony-resistant but not antimony-sensitive Leishmania donovani up-regulates host IL-10 to overexpress multidrug-resistant protein 1 B Mukherjee, R Mukhopadhyay, B Bannerjee, S Chowdhury, S Mukherjee, ... Proceedings of the National Academy of Sciences 110 (7), E575-E582, 2013 | 92 | 2013 |
| Characterisation of antimony-resistant Leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells R Mukhopadhyay, S Mukherjee, B Mukherjee, K Naskar, D Mondal, ... International journal for parasitology 41 (13-14), 1311-1321, 2011 | 91 | 2011 |
| KMP-11 DNA immunization significantly protects against L. donovani infection but requires exogenous IL-12 as an adjuvant for comparable protection against L. major S Bhaumik, R Basu, S Sen, K Naskar, S Roy Vaccine 27 (9), 1306-1316, 2009 | 79 | 2009 |
| Imipramine Is an Orally Active Drug against Both Antimony Sensitive and Resistant Leishmania donovani Clinical Isolates in Experimental Infection S Mukherjee, B Mukherjee, R Mukhopadhyay, K Naskar, S Sundar, ... PLoS neglected tropical diseases 6 (12), e1987, 2012 | 64 | 2012 |
| Hyperlipidemia offers protection against Leishmania donovani infection: role of membrane cholesterol [S] J Ghosh, S Das, R Guha, D Ghosh, K Naskar, A Das, S Roy Journal of Lipid Research 53 (12), 2560-2572, 2012 | 62 | 2012 |
| Sub-optimal dose of sodium antimony gluconate (SAG)-diperoxovanadate combination clears organ parasites from BALB/c mice infected with antimony resistant Leishmania donovani by … AK Haldar, S Banerjee, K Naskar, D Kalita, NS Islam, S Roy Experimental Parasitology 122 (2), 145-154, 2009 | 56 | 2009 |
| Leishmania donovani: a chemically defined medium suitable for cultivation and cloning of promastigotes and transformation of amastigotes to promastigotes K KAR, K MUKERJI, K NASKAR, A BHATTACHARYA, DK GHOSH The journal of protozoology 37 (4), 277-279, 1990 | 52 | 1990 |
| Heterologous priming–boosting with DNA and vaccinia virus expressing kinetoplastid membrane protein-11 induces potent cellular immune response and confers protection against … R Guha, S Das, J Ghosh, K Naskar, A Mandala, S Sundar, JC Dujardin, ... Vaccine 31 (15), 1905-1915, 2013 | 48 | 2013 |
| Imipramine exploits histone deacetylase 11 to increase the IL-12/IL-10 ratio in macrophages infected with antimony-resistant Leishmania donovani and clears organ parasites in … S Mukherjee, B Mukherjee, R Mukhopadhyay, K Naskar, S Sundar, ... The Journal of Immunology 193 (8), 4083-4094, 2014 | 47 | 2014 |
| Hybrid Cell Vaccination Resolves Leishmania donovani Infection by Eliciting a Strong CD8+ Cytotoxic T-Lymphocyte Response with Concomitant Suppression of … R Basu, S Bhaumik, AK Haldar, K Naskar, T De, SK Dana, P Walden, ... Infection and immunity 75 (12), 5956-5966, 2007 | 47 | 2007 |
| Designing therapies against experimental visceral leishmaniasis by modulating the membrane fluidity of antigen-presenting cells S Banerjee, J Ghosh, S Sen, R Guha, R Dhar, M Ghosh, S Datta, ... Infection and immunity 77 (6), 2330-2342, 2009 | 42 | 2009 |
| Antimony-resistant Leishmania donovani exploits miR-466i to deactivate host MyD88 for regulating IL-10/IL-12 levels during early hours of infection B Mukherjee, J Paul, S Mukherjee, R Mukhopadhyay, S Das, K Naskar, ... The Journal of Immunology 195 (6), 2731-2742, 2015 | 36 | 2015 |
| Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1 … SK Bhaumik, K Naskar, T De European journal of immunology 39 (8), 2146-2160, 2009 | 34 | 2009 |
| Role of Ca2+ ion on Leishmania-macrophage attachment S Misra, K Naskar, D Sarkar, DK Ghosh Molecular and cellular biochemistry 102, 13-18, 1991 | 34 | 1991 |
| Asiaticoside induces tumour-necrosis-factor-α-mediated nitric oxide production to cure experimental visceral leishmaniasis caused by antimony-susceptible and-resistant … SK Bhaumik, J Paul, K Naskar, S Karmakar, T De Journal of antimicrobial chemotherapy 67 (4), 910-920, 2012 | 23 | 2012 |
| TLR mediated GSK3β activation suppresses CREB mediated IL-10 production to induce a protective immune response against murine visceral leishmaniasis J Paul, K Naskar, S Chowdhury, T Chakraborti, T De Biochimie 107, 235-246, 2014 | 21 | 2014 |
| Evaluation of direct agglutination test (DAT) and ELISA for serodiagnosis of visceral leishmaniasis in India A Pal, K Mukerji, K Naskar, DK Ghosh, D Basu, KK Mallick Journal of clinical laboratory analysis 5 (5), 303-306, 1991 | 21 | 1991 |
